BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29754536)

  • 1. Pharmacogenetics and analgesic effects of antidepressants in chronic pain management.
    Rodieux F; Piguet V; Berney P; Desmeules J; Besson M
    Per Med; 2015 Mar; 12(2):163-175. PubMed ID: 29754536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription of antidepressants in the treatment of pain: role of pharmacogenetics].
    Rodieux F; Piguet V; Berney P; Desmeules J; Besson M
    Rev Med Suisse; 2015 Jun; 11(480):1374-9. PubMed ID: 26267942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs].
    Gex-Fabry M; Bertschy G; Kosel M; Ferrero F
    Rev Med Suisse; 2009 Sep; 5(217):1808, 1810-3. PubMed ID: 19839368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of genetic polymorphisms related to neurotransmitters and cytochrome P-450 enzymes in response to antidepressants.
    Lee MS
    Drugs Today (Barc); 2007 Aug; 43(8):569-81. PubMed ID: 17925888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in pain and its treatment.
    Stamer UM; Stüber F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Metabolites of Antidepressants in the Treatment of Depression.
    Rudorfer MV; Potter WZ
    CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
    Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of analgesics: toward the individualization of prescription.
    Rollason V; Samer C; Piguet V; Dayer P; Desmeules J
    Pharmacogenomics; 2008 Jul; 9(7):905-33. PubMed ID: 18597654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans.
    Kim H; Lee H; Rowan J; Brahim J; Dionne RA
    Mol Pain; 2006 Jul; 2():24. PubMed ID: 16848906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2009 Sep; 21(3):399-400. PubMed ID: 19794364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.